The MIBO statement for studies reporting platelet rich plasma was developed in 2016. The MIBO PRP checklist consists of twelve sections split into 23 statements. These statements include details of the study design, recipients, injury, intrervention, whole blood processing and harvesting, PRP processing and harvesting, PRP activation and delivery, post-operative care and outcome assessments. MIBO PRP aims to ensure that platelet rich plasma trials are more accurately interpreted and more easily replicated.


  • Facebook App Icon
  • Twitter App Icon
  • Google+ App Icon